Table 3.
Changes over time of the study variables. T0 = baseline; T1 = 1 month; T2 = 2 months.
| Circulating Proteins | Placebo n = 56 | EAAs n = 56 | p Interaction | ||||
|---|---|---|---|---|---|---|---|
| T0 | T1 | T2 | T0 | T1 | T2 | ||
| Albumin g/dL (n.v. 3.5–5) | 3.45 ± 0.34 | 3.50 ± 0.25 | 3.51 ± 0.34 | 3.47 ± 0.41 | 3.59 ± 0.48 | 3.7 ± 0.52 | =0.038 |
| Haemoglobin g/dL (n.v. ≥12 F; ≥13 M) | 11.8 ± 1.7 | 11.7 ± 1.6 | 11.7 ± 1.6 | 11.4 ± 1.7 | 11.8 ± 1.7 | 12.2 ± 1.6 | =0.008 |
| Prealbumin mg/dL (n.v. 18–38) | 15.9 ± 4 | 15.9 ± 3 | 16.1 ± 4.1 | 15.7 ± 5.7 | 18 ± 7.6 | 17.6 ± 6.1 | =0.3 |
| C-reactive protein mg/dL (n.v. <0.8) | 9.3 ± 6.5 | 16.9 ± 16.1 | 10.1 ± 9.4 | 20 ± 17.8 | 24.5 ± 14.8 | 13.5 ± 9.3 | =0.1 |